1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow CD30 Positive Primary Mediastinal Large B-cell Lymphoma: new trials by email Literature Review of CD30 Positive Primary Mediastinal Large B-cell Lymphoma trials Research Report on CD30 Positive Primary Mediastinal Large B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients brentuximab vedotin - CD30 Positive Primary Mediastinal Large B-cell Lymphoma, CD30-Positive Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | Completed | Abramson Cancer Center at Penn Medicine | 32 | 2013-11-01 | 2021-01-05 |
Abramson Cancer Center at Penn Medicine (1)
United States (1)